CNTNAP2 and schizophrenia: Genomic rearrangements and point mutations resulting in haploinsufficiency for CNTNAP2 have been associated with autistic spectrum disorders, schizophrenia and language disorders (Friedman et al., 2008; Rodenas-Cuadrado et al., 2014; Poot, 2015; D’Onofrio et al., 2023; Valeeva et al., 2024) although this is not universally accepted (Toma et al., 2018).